RCKT FY 2022 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$224M

Net Income

-$222M

EPS (Diluted)

$-3.26

Cash Flow

Operating Cash Flow

-$178M

Free Cash Flow

-$187M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$552M

Total Liabilities

$62M

Stockholders' Equity

$490M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$224M	-$167M	-34.1%
Net Income	-$222M	-$169M	-31.2%